 | • レポートコード：QYR9ST03919 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、免疫レパートリーシーケンスの世界市場について調査・分析し、免疫レパートリーシーケンスの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（パイロシーケンス、色素終端シーケンス、半導体シーケンス、その他）、用途別（バイオマーカー発見、感染症、ワクチン開発及び有効性、癌免疫療法、自己免疫疾患、移植拒絶及び寛容、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の免疫レパートリーシーケンス市場動向 ・主要企業別マーケットシェア ・免疫レパートリーシーケンスの種類別市場規模2014-2019 （パイロシーケンス、色素終端シーケンス、半導体シーケンス、その他） ・免疫レパートリーシーケンスの用途別市場規模2014-2019 （バイオマーカー発見、感染症、ワクチン開発及び有効性、癌免疫療法、自己免疫疾患、移植拒絶及び寛容、その他） ・免疫レパートリーシーケンスの北米市場：主要企業・種類別/用途別市場規模 ・免疫レパートリーシーケンスのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・免疫レパートリーシーケンスの中国市場：主要企業・種類別/用途別市場規模 ・免疫レパートリーシーケンスの日本国内市場：主要企業・種類別/用途別市場規模 ・免疫レパートリーシーケンスの東南アジア市場：主要企業・種類別/用途別市場規模 ・免疫レパートリーシーケンスのインド市場：主要企業・種類別/用途別市場規模 ・免疫レパートリーシーケンスの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （ArcherDX、Junom Therapeutics、Roche Holding、Illumina、ThermoFisher Scietific、Pacific Biosciences、CD Genomics、Atreca、Adaptive Biotechnologies） ・免疫レパートリーシーケンスの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.In 2018, the global Immune Repertoire Sequencing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Immune Repertoire Sequencing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immune Repertoire Sequencing development in United States, Europe and China.
The key players covered in this study
ArcherDX
Junom Therapeutics
Roche Holding
Illumina
ThermoFisher Scietific
Pacific Biosciences
CD Genomics
Atreca
Adaptive Biotechnologies
Market segment by Type, the product can be split into
Pyro-Sequencing
Dye-Terminating Sequencing
Semiconductor Sequencing
Others
Market segment by Application, split into
Biomarker Discovery
Infectious Diseases
Vaccine Development and Efficacy
Cancer Immunotherapy
Autoimmune Disease
Transplant Rejection and Tolerance
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Immune Repertoire Sequencing status, future forecast, growth opportunity, key market and key players.
To present the Immune Repertoire Sequencing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Immune Repertoire Sequencing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type (2014-2025)
1.4.2 Pyro-Sequencing
1.4.3 Dye-Terminating Sequencing
1.4.4 Semiconductor Sequencing
1.4.5 Others
1.5 Market by Application
1.5.1 Global Immune Repertoire Sequencing Market Share by Application (2014-2025)
1.5.2 Biomarker Discovery
1.5.3 Infectious Diseases
1.5.4 Vaccine Development and Efficacy
1.5.5 Cancer Immunotherapy
1.5.6 Autoimmune Disease
1.5.7 Transplant Rejection and Tolerance
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Immune Repertoire Sequencing Market Size
2.2 Immune Repertoire Sequencing Growth Trends by Regions
2.2.1 Immune Repertoire Sequencing Market Size by Regions (2014-2025)
2.2.2 Immune Repertoire Sequencing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Immune Repertoire Sequencing Market Size by Manufacturers
3.1.1 Global Immune Repertoire Sequencing Revenue by Manufacturers (2014-2019)
3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
3.2 Immune Repertoire Sequencing Key Players Head office and Area Served
3.3 Key Players Immune Repertoire Sequencing Product/Solution/Service
3.4 Date of Enter into Immune Repertoire Sequencing Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Immune Repertoire Sequencing Market Size by Type (2014-2019)
4.2 Global Immune Repertoire Sequencing Market Size by Application (2014-2019)
5 United States
5.1 United States Immune Repertoire Sequencing Market Size (2014-2019)
5.2 Immune Repertoire Sequencing Key Players in United States
5.3 United States Immune Repertoire Sequencing Market Size by Type
5.4 United States Immune Repertoire Sequencing Market Size by Application
6 Europe
6.1 Europe Immune Repertoire Sequencing Market Size (2014-2019)
6.2 Immune Repertoire Sequencing Key Players in Europe
6.3 Europe Immune Repertoire Sequencing Market Size by Type
6.4 Europe Immune Repertoire Sequencing Market Size by Application
7 China
7.1 China Immune Repertoire Sequencing Market Size (2014-2019)
7.2 Immune Repertoire Sequencing Key Players in China
7.3 China Immune Repertoire Sequencing Market Size by Type
7.4 China Immune Repertoire Sequencing Market Size by Application
8 Japan
8.1 Japan Immune Repertoire Sequencing Market Size (2014-2019)
8.2 Immune Repertoire Sequencing Key Players in Japan
8.3 Japan Immune Repertoire Sequencing Market Size by Type
8.4 Japan Immune Repertoire Sequencing Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Immune Repertoire Sequencing Market Size (2014-2019)
9.2 Immune Repertoire Sequencing Key Players in Southeast Asia
9.3 Southeast Asia Immune Repertoire Sequencing Market Size by Type
9.4 Southeast Asia Immune Repertoire Sequencing Market Size by Application
10 India
10.1 India Immune Repertoire Sequencing Market Size (2014-2019)
10.2 Immune Repertoire Sequencing Key Players in India
10.3 India Immune Repertoire Sequencing Market Size by Type
10.4 India Immune Repertoire Sequencing Market Size by Application
11 Central & South America
11.1 Central & South America Immune Repertoire Sequencing Market Size (2014-2019)
11.2 Immune Repertoire Sequencing Key Players in Central & South America
11.3 Central & South America Immune Repertoire Sequencing Market Size by Type
11.4 Central & South America Immune Repertoire Sequencing Market Size by Application
12 International Players Profiles
12.1 ArcherDX
12.1.1 ArcherDX Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immune Repertoire Sequencing Introduction
12.1.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.1.5 ArcherDX Recent Development
12.2 Junom Therapeutics
12.2.1 Junom Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immune Repertoire Sequencing Introduction
12.2.4 Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.2.5 Junom Therapeutics Recent Development
12.3 Roche Holding
12.3.1 Roche Holding Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immune Repertoire Sequencing Introduction
12.3.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.3.5 Roche Holding Recent Development
12.4 Illumina
12.4.1 Illumina Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immune Repertoire Sequencing Introduction
12.4.4 Illumina Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.4.5 Illumina Recent Development
12.5 ThermoFisher Scietific
12.5.1 ThermoFisher Scietific Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immune Repertoire Sequencing Introduction
12.5.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.5.5 ThermoFisher Scietific Recent Development
12.6 Pacific Biosciences
12.6.1 Pacific Biosciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immune Repertoire Sequencing Introduction
12.6.4 Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.6.5 Pacific Biosciences Recent Development
12.7 CD Genomics
12.7.1 CD Genomics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immune Repertoire Sequencing Introduction
12.7.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.7.5 CD Genomics Recent Development
12.8 Atreca
12.8.1 Atreca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immune Repertoire Sequencing Introduction
12.8.4 Atreca Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.8.5 Atreca Recent Development
12.9 Adaptive Biotechnologies
12.9.1 Adaptive Biotechnologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immune Repertoire Sequencing Introduction
12.9.4 Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2014-2019)
12.9.5 Adaptive Biotechnologies Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Immune Repertoire Sequencing Key Market Segments
Table Key Players Immune Repertoire Sequencing Covered
Table Global Immune Repertoire Sequencing Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Immune Repertoire Sequencing Market Size Market Share by Type 2014-2025
Figure Pyro-Sequencing Figures
Table Key Players of Pyro-Sequencing
Figure Dye-Terminating Sequencing Figures
Table Key Players of Dye-Terminating Sequencing
Figure Semiconductor Sequencing Figures
Table Key Players of Semiconductor Sequencing
Figure Others Figures
Table Key Players of Others
Table Global Immune Repertoire Sequencing Market Size Growth by Application 2014-2025 (Million US$)
Figure Biomarker Discovery Case Studies
Figure Infectious Diseases Case Studies
Figure Vaccine Development and Efficacy Case Studies
Figure Cancer Immunotherapy Case Studies
Figure Autoimmune Disease Case Studies
Figure Transplant Rejection and Tolerance Case Studies
Figure Others Case Studies
Figure Immune Repertoire Sequencing Report Years Considered
Table Global Immune Repertoire Sequencing Market Size 2014-2025 (Million US$)
Figure Global Immune Repertoire Sequencing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Immune Repertoire Sequencing Market Size by Regions 2014-2025 (Million US$)
Table Global Immune Repertoire Sequencing Market Size by Regions 2014-2019 (Million US$)
Table Global Immune Repertoire Sequencing Market Share by Regions 2014-2019
Figure Global Immune Repertoire Sequencing Market Share by Regions 2014-2019
Figure Global Immune Repertoire Sequencing Market Share by Regions 2019
Table Market Top Trends
Table Global Immune Repertoire Sequencing Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Immune Repertoire Sequencing Market Share by Manufacturers (2014-2019)
Figure Global Immune Repertoire Sequencing Market Share by Manufacturers in 2018
Table Global Immune Repertoire Sequencing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Immune Repertoire Sequencing Product/Solution/Service
Table Date of Enter into Immune Repertoire Sequencing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Immune Repertoire Sequencing Market Size by Type (2014-2019) (Million US$)
Table Global Immune Repertoire Sequencing Market Size Share by Type (2014-2019)
Figure Global Immune Repertoire Sequencing Market Size Market Share by Type (2014-2019)
Table Global Immune Repertoire Sequencing Market Size by Application (2014-2019) (Million US$)
Table Global Immune Repertoire Sequencing Market Size Share by Application (2014-2019)
Figure Global Immune Repertoire Sequencing Market Size Market Share by Application (2014-2019)
Figure Global Immune Repertoire Sequencing Revenue Market Share by Application in 2018
Figure United States Immune Repertoire Sequencing Market Size 2014-2019 (Million US$)
Table United States Key Players Immune Repertoire Sequencing Revenue (2018-2019) (Million US$)
Table United States Key Players Immune Repertoire Sequencing Market Share (2018-2019)
Table United States Immune Repertoire Sequencing Market Size by Type (2014-2019) (Million US$)
Table United States Immune Repertoire Sequencing Market Share by Type (2014-2019)
Table United States Immune Repertoire Sequencing Market Size by Application (2014-2019) (Million US$)
Table United States Immune Repertoire Sequencing Market Share by Application (2014-2019)
Figure Europe Immune Repertoire Sequencing Market Size 2014-2019 (Million US$)
Table Europe Key Players Immune Repertoire Sequencing Revenue (2018-2019) (Million US$)
Table Europe Key Players Immune Repertoire Sequencing Market Share (2018-2019)
Table Europe Immune Repertoire Sequencing Market Size by Type (2014-2019) (Million US$)
Table Europe Immune Repertoire Sequencing Market Share by Type (2014-2019)
Table Europe Immune Repertoire Sequencing Market Size by Application (2014-2019) (Million US$)
Table Europe Immune Repertoire Sequencing Market Share by Application (2014-2019)
Figure China Immune Repertoire Sequencing Market Size 2014-2019 (Million US$)
Table China Key Players Immune Repertoire Sequencing Revenue (2018-2019) (Million US$)
Table China Key Players Immune Repertoire Sequencing Market Share (2018-2019)
Table China Immune Repertoire Sequencing Market Size by Type (2014-20189) (Million US$)
Table China Immune Repertoire Sequencing Market Share by Type (2014-2019)
Table China Immune Repertoire Sequencing Market Size by Application (2014-2019) (Million US$)
Table China Immune Repertoire Sequencing Market Share by Application (2014-2019)
Figure Japan Immune Repertoire Sequencing Market Size 2014-2019 (Million US$)
Table Japan Key Players Immune Repertoire Sequencing Revenue (2018-2019) (Million US$)
Table Japan Key Players Immune Repertoire Sequencing Market Share (2018-2019)
Table Japan Immune Repertoire Sequencing Market Size by Type (2014-2019) (Million US$)
Table Japan Immune Repertoire Sequencing Market Share by Type (2014-2019)
Table Japan Immune Repertoire Sequencing Market Size by Application (2014-2019) (Million US$)
Table Japan Immune Repertoire Sequencing Market Share by Application (2014-2019)
Figure Southeast Asia Immune Repertoire Sequencing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Immune Repertoire Sequencing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Immune Repertoire Sequencing Market Share (2018-2019)
Table Southeast Asia Immune Repertoire Sequencing Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Immune Repertoire Sequencing Market Share by Type (2014-2019)
Table Southeast Asia Immune Repertoire Sequencing Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Immune Repertoire Sequencing Market Share by Application (2014-2019)
Figure India Immune Repertoire Sequencing Market Size 2014-2019 (Million US$)
Table India Key Players Immune Repertoire Sequencing Revenue (2018-2019) (Million US$)
Table India Key Players Immune Repertoire Sequencing Market Share (2018-2019)
Table India Immune Repertoire Sequencing Market Size by Type (2014-2019) (Million US$)
Table India Immune Repertoire Sequencing Market Share by Type (2014-2019)
Table India Immune Repertoire Sequencing Market Size by Application (2014-2019) (Million US$)
Table India Immune Repertoire Sequencing Market Share by Application (2014-2019)
Figure Central & South America Immune Repertoire Sequencing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Immune Repertoire Sequencing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Immune Repertoire Sequencing Market Share (2018-2019)
Table Central & South America Immune Repertoire Sequencing Market Size by Type (2014-2019) (Million US$)
Table Central & South America Immune Repertoire Sequencing Market Share by Type (2014-2019)
Table Central & South America Immune Repertoire Sequencing Market Size by Application (2014-2019) (Million US$)
Table Central & South America Immune Repertoire Sequencing Market Share by Application (2014-2019)
Table ArcherDX Company Details
Table ArcherDX Revenue in Immune Repertoire Sequencing Business (2014-2019) (Million US$)
Figure ArcherDX Revenue Growth Rate in Immune Repertoire Sequencing Business (2014-2019)
Table ArcherDX Recent Development
Table Junom Therapeutics Company Details
Table Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2014-2019)(Million US$)
Figure Junom Therapeutics Revenue Growth Rate in Immune Repertoire Sequencing Business (2014-2019)
Table Junom Therapeutics Recent Development
Table Roche Holding Company Details
Table Roche Holding Revenue in Immune Repertoire Sequencing Business (2014-2019)(Million US$)
Figure Roche Holding Revenue Growth Rate in Immune Repertoire Sequencing Business (2014-2019)
Table Roche Holding Recent Development
Table Illumina Company Details
Table Illumina Revenue in Immune Repertoire Sequencing Business (2014-2019)(Million US$)
Figure Illumina Revenue Growth Rate in Immune Repertoire Sequencing Business (2014-2019)
Table Illumina Recent Development
Table ThermoFisher Scietific Company Details
Table ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2014-2019)(Million US$)
Figure ThermoFisher Scietific Revenue Growth Rate in Immune Repertoire Sequencing Business (2014-2019)
Table ThermoFisher Scietific Recent Development
Table Pacific Biosciences Company Details
Table Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2014-2019)(Million US$)
Figure Pacific Biosciences Revenue Growth Rate in Immune Repertoire Sequencing Business (2014-2019)
Table Pacific Biosciences Recent Development
Table CD Genomics Company Details
Table CD Genomics Revenue in Immune Repertoire Sequencing Business (2014-2019)(Million US$)
Figure CD Genomics Revenue Growth Rate in Immune Repertoire Sequencing Business (2014-2019)
Table CD Genomics Recent Development
Table Atreca Company Details
Table Atreca Revenue in Immune Repertoire Sequencing Business (2014-2019)(Million US$)
Figure Atreca Revenue Growth Rate in Immune Repertoire Sequencing Business (2014-2019)
Table Atreca Recent Development
Table Adaptive Biotechnologies Company Details
Table Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2014-2019)(Million US$)
Figure Adaptive Biotechnologies Revenue Growth Rate in Immune Repertoire Sequencing Business (2014-2019)
Table Adaptive Biotechnologies Recent Development
Table Global Immune Repertoire Sequencing Market Size by Regions (Million US$) 2019-2025
Figure Global Immune Repertoire Sequencing Market Size Share by Regions (2019-2025)
Figure Global Immune Repertoire Sequencing Market Size Share by Regions in 2025
Figure United States Immune Repertoire Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Immune Repertoire Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure China Immune Repertoire Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Immune Repertoire Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Immune Repertoire Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure India Immune Repertoire Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Immune Repertoire Sequencing Market Size Forecast (2019-2025)(Million USD)
Table Global Immune Repertoire Sequencing Market Size by Product (2019-2025) (Million US$)
Figure Global Immune Repertoire Sequencing Market Size by Product (2019-2025)
Figure Global Immune Repertoire Sequencing Market Size by Product in 2025
Table Global Immune Repertoire Sequencing Market Size by Application (2019-2025) (Million US$)
Figure Global Immune Repertoire Sequencing Market Size by Application (2019-2025)
Figure Global Immune Repertoire Sequencing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
次世代シーケンス（NGS）の世界市場：市場規模・現状・予測 Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis where the bases of small fragments of DNA are sequentially identified from signals emitted, and each fragment is resynthesized fro…- メタゲノミクスシーケンスの世界市場：市場規模・現状・予測 Metagenomics is the process of cloning and analyzing the genomes of an organism without culturing them in a community.The major factors driving the growth of the global metagenomics market include technological advancements in DNA sequencing. Moreover, metagenomics is applicable across a broad range…
- メタゲノミクスシーケンスの世界市場：市場規模・現状・予測 Metagenomics is the process of cloning and analyzing the genomes of an organism without culturing them in a community.The major factors driving the growth of the global metagenomics market include technological advancements in DNA sequencing. Moreover, metagenomics is applicable across a broad range…
- 世界のDNAシーケンス市場：専門的調査 The global DNA Sequencing market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on DNA Sequencing volume and value at global level, regional level and company level. From a global perspective, this…
- 次世代シーケンス（NGS）の世界市場：市場規模・現状・予測 NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing.The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud comput…